CSF(600654)
Search documents
中安科: 关于回购注销部分限制性股票减少注册资本暨通知债权人的公告
Zheng Quan Zhi Xing· 2025-08-12 16:13
Core Viewpoint - The company plans to repurchase and cancel a total of 3,481,750 restricted shares due to the departure of 9 incentive recipients who no longer qualify for the incentive program [1] Group 1: Repurchase and Cancellation Details - The company held a board meeting on August 12, 2025, where it approved the repurchase and cancellation of restricted shares [1] - The repurchase involves shares granted under the 2023 Stock Option and Restricted Stock Incentive Plan [1] - The total number of restricted shares to be repurchased and canceled in previous instances includes 1,130,000 shares and 62,000 shares from other meetings [2][3] Group 2: Impact on Capital Structure - Following the repurchase and cancellation of 10,426,674 restricted shares, the company's total shares will decrease from 2,876,607,560 to 2,866,180,886 [5] - The repurchase price for the restricted shares is set at 1.25 yuan per share [3][4] Group 3: Notification to Creditors - The company is notifying creditors about the reduction in registered capital due to the repurchase of restricted shares, allowing them 45 days to claim their debts [5] - Creditors must provide valid documentation to request debt repayment or guarantees [6]
中安科: 上海君澜律师事务所关于中安科股份有限公司2023年股票期权与限制性股票激励计划回购注销部分限制性股票之法律意见书
Zheng Quan Zhi Xing· 2025-08-12 16:13
Core Viewpoint - The legal opinion letter from Shanghai Junlan Law Firm confirms that Zhong An Ke Co., Ltd. has obtained the necessary approvals and followed the required procedures for the repurchase and cancellation of certain restricted stocks as part of its stock incentive plan [1][6]. Group 1: Approval and Authorization - The board of directors has approved the proposal for the repurchase and cancellation of restricted stocks [4]. - The repurchase has received the necessary authorization from the shareholders at the first extraordinary general meeting of 2023 [6]. Group 2: Details of the Repurchase - The repurchase is due to nine incentive recipients leaving the company, resulting in the cancellation of 3,481,750 shares of restricted stock that were granted but not yet released [4][5]. - The repurchase price is set at 1.25 yuan per share, which is the same as the initial grant price [5]. - The funds for the repurchase will be sourced entirely from the company's own funds [5]. Group 3: Impact of the Repurchase - The repurchase will not have a substantial impact on the company's financial status or operational results [5][6]. - The management team's diligence and responsibility will remain unaffected by this repurchase [5][6]. Group 4: Information Disclosure - The company will timely disclose relevant documents regarding the board's decision and the repurchase process, in compliance with legal and regulatory requirements [6]. - The company has fulfilled its current information disclosure obligations and will continue to do so as required [6].
中安科: 关于回购注销部分限制性股票的公告
Zheng Quan Zhi Xing· 2025-08-12 16:13
Core Viewpoint - The company has decided to repurchase and cancel a total of 3,481,750 restricted shares at a repurchase price of 1.25 yuan per share, following the authorization from the shareholders' meeting and the board's approval [1][11][12] Summary by Sections Stock Repurchase and Cancellation - The number of restricted shares to be repurchased and canceled is 3,481,750 shares [1] - The repurchase price is set at the grant price of 1.25 yuan per share [11] - The decision to implement this repurchase was authorized by the shareholders' meeting held on April 3, 2023 [1][12] Approval Process and Implementation Progress - The company held its first temporary shareholders' meeting in 2023, where the proposal for the stock incentive plan was approved [2] - The independent directors expressed clear agreement on the proposal, and legal opinions were provided [2] - The company conducted a self-examination regarding insider trading prior to the announcement of the incentive plan and found no violations [2] Impact on Share Capital Structure - Following the repurchase and cancellation, the total number of shares will decrease from 2,876,607,560 to 2,866,180,886 shares [11] - The repurchase will not have a substantial impact on the company's financial status or operational results [11][12] Future Work Arrangements - The company will follow legal procedures for capital reduction, including notifying creditors and updating company registration [12] - The remuneration and assessment committee has agreed that the repurchase complies with relevant laws and regulations [12] Legal Opinions - The legal opinion confirms that the repurchase has obtained necessary approvals and adheres to relevant regulations, ensuring no adverse effects on the company's management or financial condition [12]
中安科:关于回购注销部分限制性股票的公告
Zheng Quan Ri Bao· 2025-08-12 13:38
Core Viewpoint - The company announced a plan to repurchase and cancel a portion of its restricted stock as part of its incentive plan, indicating a strategic move to manage equity compensation and potentially enhance shareholder value [2] Group 1: Company Actions - The company will hold its 12th Board of Directors' fourth meeting on August 12, 2025, to review and approve the proposal for repurchasing and canceling certain restricted stocks [2] - A total of 3,481,750 shares will be repurchased at the grant price of 1.25 yuan per share, reflecting a proactive approach to managing its stock incentive program [2]
中安科:第十二届董事会第四次会议决议公告
Zheng Quan Ri Bao· 2025-08-12 12:15
(文章来源:证券日报) 证券日报网讯 8月12日晚间,中安科发布公告称,公司第十二届董事会第四次会议审议通过了《关于回 购注销部分限制性股票的议案》。 ...
中安科(600654) - 关于回购注销部分限制性股票的公告
2025-08-12 09:17
中安科股份有限公司 关于回购注销部分限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 证券代码:600654 证券简称:中安科 公告编号:2025-064 一、本次股权激励计划履行的相关审批程序及实施进展情况 1、2023 年 3 月 17 日,公司召开第十一届董事会第六次会议审议通过了《关 于<公司 2023 年股票期权与限制性股票激励计划(草案)>及其摘要的议案》《关 于<公司 2023 年股票期权与限制性股票激励计划实施考核管理办法>的议案》《关 于提请股东大会授权董事会办理公司股权激励计划有关事项的议案》,公司独立 董事对上述议案发表了明确同意的独立意见,律师出具了相应的法律意见书。 中安科股份有限公司(以下简称"公司")于 2025 年 8 月 12 日召开公司第 十二届董事会第四次会议,审议并通过了《关于回购注销部分限制性股票的议案》, 同意对公司《2023 年股票期权与限制性股票激励计划》(以下简称"激励计划") 首次授予和预留授予的部分已获授但尚未解除限售的限制性股票进行回购注销 ...
中安科(600654) - 上海君澜律师事务所关于中安科股份有限公司2023年股票期权与限制性股票激励计划回购注销部分限制性股票之法律意见书
2025-08-12 09:16
上海君澜律师事务所 之 法律意见书 二〇二五年八月 上海君澜律师事务所 法律意见书 关于 中安科股份有限公司 2023 年股票期权与限制性股票激励计划 回购注销部分限制性股票 回购注销部分限制性股票之 法律意见书 致:中安科股份有限公司 上海君澜律师事务所(以下简称"本所")接受中安科股份有限公司(以下简称 "公司"或"中安科")的委托,根据《上市公司股权激励管理办法》(以下简称 "《管理办法》")《中安科股份有限公司 2023 年股票期权与限制性股票激励计划》(以 下简称"《激励计划》"或"本次激励计划")的规定,就中安科回购注销本次激励计 划部分限制性股票(以下简称"本次回购注销")相关事项出具本法律意见书。 对本法律意见书,本所律师声明如下: (一)本所律师依据《中华人民共和国证券法》《律师事务所从事证券法律业务管 理办法》和《律师事务所证券法律业务执业规则(试行)》等规定及本法律意见书出具 日以前已经发生或者存在的事实,严格履行了法定职责,遵循了勤勉尽责和诚实信用 原则,进行了充分的核查验证,保证本法律意见所认定的事实真实、准确、完整,所 发表的结论性意见合法、准确,不存在虚假记载、误导性陈述或者重大 ...
中安科:8月12日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-12 09:16
中安科(SH 600654,收盘价:3.49元)8月12日晚间发布公告称,公司第十二届第四次董事会会议于 2025年8月12日以通讯表决方式召开。会议审议了《关于回购注销部分限制性股票的议案》等文件。 (文章来源:每日经济新闻) 2024年1至12月份,中安科的营业收入构成为:安保押运占比62.37%,安防占比37.1%,房屋租赁占比 0.35%,新能源占比0.18%,其他行业占比0.01%。 ...
中安科(600654) - 关于回购注销部分限制性股票减少注册资本暨通知债权人的公告
2025-08-12 09:15
证券代码:600654 证券简称:中安科 公告编号:2025-065 中安科股份有限公司 关于回购注销部分限制性股票减少注册资本暨通知 债权人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、通知债权人的原因 (一)本次拟回购注销 中安科股份有限公司(以下简称"公司")于 2025 年 8 月 12 日召开公司第 十二届董事会第四次会议,审议并通过了《关于回购注销部分限制性股票的议案》。 鉴于首次授予限制性股票和预留授予限制性股票的共计 9 名激励对象因个 人原因已离职,根据《2023 年股票期权与限制性股票激励计划》(以下简称"《激 励计划》")的规定该 9 名激励对象不再具备激励资格,将由公司回购注销该 9 名激励对象已获授未解除限售的 3,481,750 股限制性股票。 上述回购注销事项已得到公司 2023 年第一次临时股东大会的授权,无需提 交公司股东大会审议。限制性股票回购注销事项的具体内容详见公司于 2025 年 8 月 13 日在指定信息披露媒体发布的《关于回购注销部分限制性股票的公告》 (公告编号:2 ...
中安科(600654) - 第十二届董事会第四次会议决议公告
2025-08-12 09:15
证券代码:600654 证券简称:中安科 公告编号:2025-063 中安科股份有限公司 第十二届董事会第四次会议决议公告 经与会董事表决,会议审议通过如下决议: 审议通过《关于回购注销部分限制性股票的议案》 根据公司《2023 年股票期权与限制性股票激励计划》的规定,本次拟回购 注销的限制性股票数量为 3,481,750 股。 具体内容详见公司同日在上海证券交易所网站(www.sse.com.cn)披露的《关 于回购注销部分限制性股票的公告》(公告编号:2025-064)。 表决情况:9 票同意,0 票反对,0 票弃权。 特此公告。 中安科股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 中安科股份有限公司(以下简称"公司")第十二届董事会第四次会议于 2025 年 8 月 12 日以通讯表决方式召开。会议通知于 2025 年 8 月 6 日以电话、 电子邮件方式向全体董事发出。本次会议应到董事 9 人,实到董事 9 人。本次会 议由吴博文先生主持。本次会议的召集、召开及表决程序符合《公司 ...